| [1] |
Montes de Oca M, Pérez-Padilla R. Global Initiative for Chronic Obstructive Lung Disease (GOLD)-2017: The alat perspective[J]. Arch Bronconeumol, 2017, 53(3): 87-88.
|
| [2] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].全科医学临床与教育, 2013, 36(5): 255-264.
|
| [3] |
张维杰，李辉，刘相海，等.联合吸入布地奈德/福莫特罗和噻托溴铵在治疗中重度稳定期慢性阻塞性肺疾病中的临床疗效研究[J].中国医药指南, 2013, 11(36): 148-149.
|
| [4] |
卢琴华.雾化吸入舒利迭辅助治疗慢性阻塞性肺病的疗效与抗炎作用的临床观察[J].中国医药导报, 2012, 9(17): 103-104.
|
| [5] |
Howarth PH, Beckett P, Dahl R. The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients[J]. Respir Med, 2000, 94 Suppl F: S22-25.
|
| [6] |
徐建刚，周向东.信必可都保吸入对中重度COPD患者的疗效观察[J].中国医药指南, 2013, 11(35): 299.
|
| [7] |
Nair S, Thomas E, Pearson SB, et al. A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD[J]. Chest, 2005, 128(1): 48-54.
|
| [8] |
Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial[J]. Am J Respir Crit Care Med, 2002, 165(5): 698-703.
|
| [9] |
沈新联.雾化吸入不同剂量布地奈德混悬液对AECOPD患者的治疗作用及安全性评估8076[J].临床肺科杂志, 2009, 14(5): 657-658.
|
| [10] |
黄承龙，于锋，葛卫红，等.慢性阻塞性肺疾病急性加重期的病原菌分布与抗菌药物的应用分析[J].安徽医药, 2015, 19(6): 1199-1201.
|
| [11] |
Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. Azithromycin: mechanisms of action and their relevance for clinical applications[J]. Pharmacol Ther, 2014, 143(2): 225-245.
|
| [12] |
Ramos FL, Criner GJ. Use of long-term macrolide therapy in chronic obstructive pulmonary disease[J].Curr Opin Pulm Med, 2014, 20(2): 153-158.
|
| [13] |
袁法常.慢性阻塞性肺疾病稳定期应用小剂量长期阿奇霉素治疗的疗效分析[J].临床合理用药杂志, 2013, 6(36): 38-39.
|
| [14] |
黄招兰，杨贵丽，王惠玲，等.小剂量阿奇霉素治疗对慢性阻塞性肺疾病稳定期老年患者肺功能和炎症因子的影响[J].中国老年学, 2016, 36(1): 135-136.
|
| [15] |
Canut A, Martín-Herrero JE, Labora A, et al. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? a therapeutic outcomes model[J]. J Antimicrob Chemother, 2007, 60(3): 605-612.
|
| [16] |
王瑞.莫西沙星治疗慢性阻塞性肺疾病急性加重期疗效和安全性的研究[J].中国实用医药, 2016, 11(8): 130-131.
|
| [17] |
Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD[J]. Respiration, 1999, 66(6): 495-500.
|
| [18] |
Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial[J].Lancet, 365(9470): 1552-1560.
|
| [19] |
张芳，张莉.阿托伐他汀在COPD治疗中的作用[J].临床肺科杂志, 2014, 43(2): 346-347.
|
| [20] |
张丽琴，陈兴无，张伟，等.辛伐他汀对慢性阻塞性肺疾病患者气道炎症部分指标的影响[J].中国老年学, 2012, 32(11): 2260-2261.
|
| [21] |
王玲玲，张旭华，刘朔，等.长期应用小剂量氨茶碱对稳定期慢性阻塞性肺疾病患者、动物外周血、骨髓粒细胞增殖的影响[J].中国医学工程, 2011, 10(6): 1-3.
|
| [22] |
Viglio S, Stolk J, Luisetti M, et al. From micellar electrokinetic chromatography to liquid chromatography-mass spectrometry: revisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease[J]. Electrophoresis, 2014, 35(1): 109-118.
|
| [23] |
Szalai Z, Molnár TF, Lőrinczy D. Differential scanning calorimetry (DSC) of blood serum in chronic obstructive pulmonary disease (COPD)[J]. Journal of Thermal Analysis & Calorimetry, 2013, 113(1): 259-264.
|
| [24] |
常琦.盐酸氨溴索治疗慢性阻塞性肺疾病急性发作期80例临床观察[J].现代预防医学, 2012, 39(6): 1591-1593.
|
| [25] |
时旭，王荣，安晓琴，等.咳嗽变异性哮喘患者外周血白三烯D4和尿白三烯E4水平[J].中华内科杂志, 2012, 51(1): 54-55.
|
| [26] |
Yu MQ, Liu XS, Wu HX, et al. ERK1/2 Promotes cigarette smoke-induced rat pulmonary artery smooth muscle cells proliferation and pulmonary vascular remodeling via up-regulating cycline1 expression[J].华中科技大学学报(医学英德文版), 2013, 33(3): 315-322.
|
| [27] |
李艳萍.抗凝治疗用于慢性阻塞性肺疾病急性加重期的临床评价[J].医学信息, 2014, 28(37): 470.
|
| [28] |
陈美红.美托洛尔治疗慢性阻塞性肺部疾病合并心血管疾病的疗效观察[J].现代实用医学, 2013, 25(7): 758-759.
|
| [29] |
李琛琛，王蕾.美托洛尔治疗慢性阻塞性肺疾病合并心血管疾病的疗效分析[J].中国现代药物应用, 2015, 9(21): 137-138.
|
| [30] |
孙少贵.慢性阻塞性肺疾病治疗的研究进展[J].中外健康文摘, 2013, 10(48): 263-264.
|
| [31] |
王书祥.无创呼吸机联合纳洛酮对老年COPD并发呼吸衰竭的治疗效果初评[J].中国继续医学教育, 2015, 7(33): 160-161.
|
| [32] |
高欣.无创通气对老年间质性肺炎合并呼吸衰竭患者临床疗效观察[J].中国继续医学教育, 2015, 7(24): 113-114.
|
| [33] |
Hsu MF, Ho SC, Kuo HP, et al. Mini-nutritional assessment (MNA) is useful for assessing the nutritional status of patients with chronic obstructive pulmonary disease: a cross-sectional study[J]. COPD, 2014, 11(3): 325-332.
|
| [34] |
Hallin R, Janson C, Arnardottir RH, et al. Relation between physical capacity, nutritional status and systemic inflammation in COPD[J]. Clin Respir J, 2011, 5(3): 136-142.
|
| [35] |
Bartley J. Vitamin D: emerging roles in infection and immunity[J]. Expert Rev Anti Infect Ther, 2010, 8(12): 1359-1369.
|
| [36] |
Camillo CA, Langer D, Osadnik CR, et al. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2671-2679.
|
| [37] |
杜志旺.运动训练在慢性阻塞性肺疾病康复治疗中的应用和护理[J].中国现代药物应用, 2015, 9(11): 211-212.
|
| [38] |
王君，马春平，赵玉才.胸腔镜手术治疗重度COPD的疗效分析[J].临床肺科杂志, 2014, 19(3): 420-422.
|
| [39] |
金志贤，周开华，毕虹，等.间充质干细胞治疗慢性阻塞性肺疾病机制研究进展[J].山东医药, 2015, 55(2): 96-98.
|
| [40] |
李红梅，高欢玲，刘爱梅，等.老年慢性阻塞性肺疾病患者生活质量质性研究[J].中国老年学, 2017, 37(5): 1244-1246.
|